RazorMetrics Named to Deloitte Technology Fast 500 for Second Consecutive Year
PR Newswire
AUSTIN, Texas, Nov. 18, 2026
Repeat recognition highlights sustained revenue growth and growing demand for AI-driven prescription drug cost containment solutions that support physicians' needs
AUSTIN, Texas, Nov. 18, 2026 /PRNewswire/ -- RazorMetrics, a leading innovator in pharmacy cost containment technology, today announced it ranked No. 20 on the 2026 Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing tech companies in North America, now in its 32nd year. The company also ranked No. 1 in Texas and No. 3 in the Health Tech and Medical Devices sector nationwide. The company grew 4488% during 2022 to 2025.
Building on its initial appearance on the list in 2025, where the company ranked No. 12 overall, No. 1 among life sciences companies in Texas and No. 2 among life sciences companies nationwide, RazorMetrics returns this year as it continues helping organizations address rising prescription drug costs. Its platform identifies lower-cost, clinically appropriate medication alternatives within existing prescribing workflows, helping reduce unnecessary pharmacy spending while supporting affordability and patient outcomes.
"Our growth reflects the results we're delivering to clients, and we're honored to be recognized by Deloitte for a second year," said Tom Dorsett, CEO and co-founder of RazorMetrics. "Being named No. 1 in Texas is an especially meaningful recognition for us as an Austin-based company, and for me as a native Austinite. We've had a strong year of growth nationwide, and I'm proud to see our physician-centered approach supporting health plans and care teams well beyond our Texas roots."
Throughout 2026, RazorMetrics continued to build its pharmacy cost containment approach around physicians' needs, helping them address prescription affordability while supporting patient access and outcomes. The company expanded its national footprint, with its provider network reaching nearly 1.7 million unique prescribers nationwide.
In its 2026 Physician Drug Cost Survey of more than 100 U.S. physicians, RazorMetrics examined how drug costs affect treatment, the administrative burden of addressing affordability, and physicians' ability to act on lower-cost, clinically appropriate alternatives. The findings and its growing network reinforce the focus of RazorMetrics' technology: putting timely, patient-specific options into existing workflows so physicians can address affordability while keeping clinical decisions in their hands.
"RazorMetrics was built on the belief that organizations should not have to choose between managing prescription drug costs and helping members access the medications they need," said Siva Mohan, MD, co-founder, president, and chief medical officer of RazorMetrics. "Our growth has been made possible by listening to physicians about the challenges they face, building technology that fits into their workflows, and helping them address medication costs without compromising patient care."
Overall, the 2026 Technology Fast 500 companies achieved revenue growth ranging from 97% to 66,330% over the three-year time frame, with an average growth rate of 1,134%.
For more information about RazorMetrics, visit www.razormetrics.com.
About the 2026 Deloitte Technology Fast 500
Now in its 32nd year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2022 to 2025.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or proprietary technology that significantly contributes to the company's operating revenues. Companies must have base-year (fiscal year 2022) operating revenues of at least US$50,000, and current-year (fiscal year 2025) operating revenues of at least US$5 million, with a growth rate of 50% or greater. Additionally, companies must be in business for a minimum of four years and be headquartered within North America (United States and Canada).
About RazorMetrics
RazorMetrics builds pharmacy cost containment technology that finds and captures savings automatically. Its proprietary platform initiates medication switching, deprescription, and deduplication in real time, adapting to each client's plan, preferences, and formulary. RazorMetrics plugs directly into prescribers' existing workflows, putting medical decisions where they belong: in physicians' hands. Based in Austin, Texas, RazorMetrics serves self-funded employers, health plans, PBMs, and other organizations, bringing clarity, efficiency, and greater value to pharmacy benefits. Learn more at www.razormetrics.com.
Media Contact
Brynn Spicher
anthonyBarnum Public Relations
brynn.spicher@anthonybarnum.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/razormetrics-named-to-deloitte-technology-fast-500-for-second-consecutive-year-302944218.html
SOURCE RazorMetrics

